Thursday , January 20 2022

The series of three medicines is withdrawn from the market



[ad_1]

Cancel Mylan Laboratories Limited film-coated tablets Amlodipine / Valsartan Teva 10 mg / 160 mg, Amlodipine / Valsartan Teva 5 mg / 160 mg en Vanatex HCT 80 mg / 12.5 mg.

These medicines are used for high blood pressure, recent infarction or heart failure.

The top of IWP, Gintautas Barcys, does not give you a demonstration of the & # 39; the situation, but they are advised to check the doctors with those who buy them.

"Their supply to the market is stopped, but it's not what comes to the tablet. The amounts of these invalids are not high there," said Barcys, a BNS.

According to the head of service there are data on & # 39; re-collecting on how many of these medicines were delivered to pharmacies.

According to G. Barcio, in September, Lithuanian drugstores from the manufacturers received two packages of "Vanatex HCT 80 mg / 12.5 mg" and about 2 thousand. Amlodipine / Valsartan Teva 10 mg / 160 mg "en" Amlodipine / Valsartan Teva 5 mg / 160 mg ".

All the series of medicines with the whisker of the manufacturer have already been withdrawn from Switzerland, Croatia, Italy and Spain. Other countries that have been working with this active substance in their markets have been canceled in future plans.

In Czech, Icelandic, Swedish, Tsjiper and Finnish brand there are no medicines with the active substance of # 39; called the manufacturer.

In July, the European Medical Association has already announced the discovery of medicines that the substance has been named by the Chinese company Zhejiang Huahai Pharmaceuticals. Her active ingredients, Valsartan, also found NDEA incubation.

It is forbidden to copy and publish the text of this publication without the written consent of UAB "BNS".

[ad_2]
Source link